NASDAQ: VCYT
Veracyte Inc Stock Ownership - Who owns Veracyte?

Insider buying vs selling

Have Veracyte Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Phillip G. FebboChief Scientific Med Officer2025-10-068,349$36.02
$300.71kSell
Robert S. EpsteinDirector2025-10-0110,000$7.94
$79.40kBuy
Robert S. EpsteinDirector2025-10-0121,473$35.08
$753.21kSell
John LeiteChief Commercial Officer-CLIA2025-10-012,539$35.00
$88.87kSell
Annie McGuireSVP General Counsel2025-10-012,160$35.00
$75.61kSell
Annie McGuireSVP General Counsel2025-09-192,283$33.69
$76.92kSell
Marc StapleyChief Executive Officer2025-09-047,667$30.41
$233.13kSell
Rebecca ChambersChief Financial Officer2025-09-025,371$30.11
$161.72kSell
Marc StapleyChief Executive Officer2025-09-027,914$30.11
$238.29kSell
Jonathan WygantVP Chief Accounting Officer2025-09-021,648$30.11
$49.62kSell

1 of 7

VCYT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VCYT insiders and whales buy or sell their stock.

VCYT Shareholders

What type of owners hold Veracyte Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC10.35%8,107,782$286.45MInstitution
Vanguard Group Inc10.34%8,100,351$286.19MInstitution
Blackrock Inc9.87%7,728,527$273.05MInstitution
Artisan Partners Limited Partnership8.07%6,321,775$223.35MInstitution
Ark Investment Management LLC4.85%3,800,089$134.26MInstitution
Samuel D. Colella4.62%3,616,221$127.76MInsider
Versant Ventures III LLC4.62%3,616,221$127.76MInsider
Brian G. Atwood4.62%3,616,221$127.76MInsider
Brook H. Byers4.54%3,551,929$125.49MInsider
Tpg Group Holdings Sbs Advisors Inc4.54%3,551,929$125.49MInsider

1 of 3

VCYT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VCYT66.66%33.34%Net SellingNet Selling
ZLAB3.93%1.79%Net BuyingNet Buying
KNSA52.54%9.26%Net SellingNet Selling
SRRK61.10%38.90%Net SellingNet Buying
IDYA92.77%7.23%Net Buying

Veracyte Stock Ownership FAQ

Who owns Veracyte?

Veracyte (NASDAQ: VCYT) is owned by 108.94% institutional shareholders, 54.49% Veracyte insiders, and 0.00% retail investors. Samuel D. Colella is the largest individual Veracyte shareholder, owning 3.62M shares representing 4.62% of the company. Samuel D. Colella's Veracyte shares are currently valued at $130.47M.

If you're new to stock investing, here's how to buy Veracyte stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.